Dr. Lal Path Labs Ltd. CC-Nov25.pdf · 2025-10-31
Hi, sir. Good evening. So, just a point that was mentioned in your presentation, right? So, just wanted to understand that in the Indian market, there has been a narrowing penetration in non-Tier-1 cities over the last 5 to 6 years, as you can see in the ppt , right? So, does that mean that demand for pathology in such markets could be a headwind in terms of if you look at our strategy of expanding into non-Tier-1 market?
The penetration of diagnostics across Tier -2, 3, 4 cities, if you see Page 34 of your presentation.